Références
Pereira FA, Mudgil AV, Rosmarin DM, (2007) Toxic epidermal necrolysis. J Am Acad Dermatol 56: 181–200
FDA Drug Safety Communication: FDA warns of rare but serious skin reactions with the pain reliever/fever reducer acetaminophen. 2013. Disponible sur internet: https://www.fda.gov/Drugs/Drug-Safety/ucm363041.htm. Consulté le 25/03/2017
Lebrun-Vignes B, Guy C, Jean-Pastor MJ, Gras-Champel V, Zénut M et Réseau français de centres régionaux de pharmacovigilance et Groupe FISARD de la SFD, (2015). Paracétamol et syndrome de Lyell/syndrome de Stevens-Johnson: analyse de la base nationale de pharmacovigilance. Ann Dermatol Venereol 142(Suppl): S490
Mangla K, Rastogi S, Goyal P, Solanki RB, Rawal RC, (2005) Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: an open uncontrolled study. Indian J Dermatol Venereol Leprol 71: 398–400
Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M, (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 58: 33–40
Lee HY, Lim YL, Thirumoorthy T, Pang SM, (2013) The role of intravenous immunoglobulin in toxic epidermal necrolysis: A retrospective analysis of 64 patients managed in a specialized center. Br J Dermatol 169: 1304–1309
Valeyrie-Allanore L, Roujeau JC (2007) Syndrome de Lyell (nécrolyse épidermique toxique). EMC (Elsevier Masson SAS, Paris), Dermatologie, 98-270-A-10
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alouani, I., Bkiyar, H., Fihmi, N. et al. Un nouveau cas de nécrolyse épidermique toxique chez un enfant de huit ans. Méd. Intensive Réa 26, 440–442 (2017). https://doi.org/10.1007/s13546-017-1302-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-017-1302-z